Fermenta Biotech Ltd
458.35
INR
-6.65
(-1.43%)
ISIN
INE225B01021
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Prashant Prabhakar Nagre
- Full Time Employees
- 891
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- DIL Complex Mumbai MH India 400610
- IPO Date
- Jan 4, 1990
- Website
- fermentabiotech.com
- Similar Companies
- Business
- Fermenta Biotech Ltd. (FERMENTA.BO) manufactures and markets premium-grade active pharmaceutical ingredients (APIs), nutritional premixes, enzymes, and biotechnology products primarily for pharmaceutical, nutraceutical, food fortification, and environmental sectors; its core offerings include Vitamin D3 in various formats such as VITADEE 100 SD (spray-dried variant with Certificate of Suitability from EDQM), Vitamin K1 (API and spray-dried), Vitamin E50, fish oil cholesterol, niche APIs like Phenyramidol and silicon dioxide, proprietary enzymes such as Fermase PS 250 and Penicillin G Acylase for beta-lactam antibiotic synthesis (Amoxicillin, Ampicillin, Cephalexin, Cefadroxil), customized premixes for staple food fortification, dietary supplements, Ready-to-Use Therapeutic Food (RUTF), Ready-to-Use Supplementary Food (RUSF), bakery, confectionery, beverages, and health drinks, as well as comprehensive environmental solutions encompassing wastewater treatment plants design, engineering, construction, operation, maintenance, and electromechanical equipment. The company operates state-of-the-art R&D and manufacturing facilities in Thane (headquarters and R&D), Kullu (Himachal Pradesh, premix plant), Dahej (Gujarat, GMP-compliant API facility), and Tirupati (Andhra Pradesh, fortified rice kernel facility), with subsidiaries including Fermenta Biotech GmbH (Germany) and Fermenta USA LLC serving global clientele across India, Europe, the United States, and other international markets. Founded in 1951 by Dr. Datla Venkata Krishnam Raju as International Franchises Private Limited (formerly DIL Ltd.), Fermenta Biotech maintains a non-China dependent supply chain for Vitamin D3 and holds strategic investments in associates focused on bulk drugs, sporting, and health awareness activities, alongside a real estate leasing business for ITES properties in Thane. Recent developments include the October 2025 investment of Rs 7.9 crore via rights issue in wholly-owned subsidiary Fermenta Environment Solutions Private Limited to support working capital and expansion in sustainable environmental systems; board approval for slump sale of its environmental solutions business to the same subsidiary; receipt of Indian Patent Office process patent for plant-based Vitamin D3; Global Alliance for Improved Nutrition (GAIN) Letter of Approval as premix supplier; Memorandum of Understanding with National Institute of Food Technology, Entrepreneurship and Management – Thanjavur (NIFTEM-T) for fortification initiatives; commissioning of fortified rice kernel facility in Tirupati; inauguration of premix plant in Kullu; EU GMP certification for Dahej API facility; entry into its 75th year milestone in 2025 celebrating legacy in green chemistry and nutritional wellness; and recognition as supplier of dry/liquid premix blends meeting global quality standards.